CUBED BIOTECH INC.

Cubed Biotech Inc. is a Canadian biotechnology company working to develop and manufacture psychedelic medicine, intending to disrupt the current treatments of mental illness and addiction. They plan to cultivate, extract, and synthesize natural entheogens (Psilocybin from Mushrooms, Mescaline from Cacti, along with DMT & MAO-inhibitors from Ayahuasca) and develop its own proprietary novel stacked API compound through clinical trials in order to achieve to pharmaceutical-grade distribution and commercialization. The company intends to become a Health Canada licensed Contract Development & Manufacturing Organization. Cubed Biotech was founded in 2020 and is based in Quebec, Canada. They are focused on becoming a leading psychedelic medicine manufacturer and a trusted partner for pharmaceutical companies worldwide. They have a cGMP facility to cultivate, extract & synthesize psilocybin and other psychedelics and manufacture pharmaceutical grade psychedelic medicines. They are also working on two stacked active pharmaceutical ingredient ("API") drugs: Psilocybin / Mescaline Compound and Ayahuasca Compound (DMT with MAO inhibitors).